Hikma Pharmaceuticals USA INC 2026-05-06 Health serious FDA
Health · FDA · Recall #FDA-D-0526-2026
Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose… Recall
Issued May 6, 2026 · Hikma Pharmaceuticals USA INC
In May 2026, Hikma Pharmaceuticals USA INC recalled the Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
What you should do
- 1 Stop using Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single Dose… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Hikma Pharmaceuticals USA INC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Hikma Pharmaceuticals USA INC
- Category
- Health
- Recall date
- May 6, 2026
- Units affected
- Not reported
- Sold at
- US Nationwide.
- Recall number
- FDA-D-0526-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Hikma Pharmaceuticals USA INC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.